Fig 2: Evolving Competitive Landscape in GLP-1 Based Obesity Medications Abbreviations: AHI: Apnea Hyperpnea Index, CKD: Chronic Kidney Disease, MONW: Metabolic Obesity Normal Weight, OOP: Out-of-pocket, OSA: Obstructive Sleep Apnea, WRC: Weight- related comorbidity
Vergoeding GLP-1 bij DM2 zonder hoog risico blijft beperkt
There are some that have very good quality-control standards, but others may not. The scoop on compounded GLP-1 drugs This is how the story of compounded GLP-1 drugs started: a few years ago the U.S
3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium inner salt, (3-carboxy2-hydroxypropyl) trimethylammonium hydroxide inner salt, 3-hydroxy-4-N-trimethylaminobutyrate, B-hydroxy-N-trimethyl aminobutyric acid, Beta-hydroxy-gamma-trimethylammonium butyrate, B(t) Factor, Carnitine, Carnitor, D-Carnitine, DL-Carnitine, Facteur B(t), L-3-hydroxy-4-(trimethylammonium)-butyrate, Levocarnitine, Lvocarnitine, Levocarnitine Fumurate, L-Carnitina, L-Carnitine Fumarate, L-Carnitine L-Tartrate, L-Carnitine Tartrate, (R)-(3-carboxy-2-hydroxypropyl) trimethylammonium hydroxide, (R)-3-hydroxy-4-trimethylammonio-butyrate, Vitacarn, Vitamin B(t), Vitamine B(t)
